Business
The Rhythm (ASX:RHY) share price surges on cancer testing milestone
The Rhythm Biosciences Ltd (ASX: RHY) share price has opened higher on Tuesday after the successful completion of Study 6 for its ColoSTAT product. At the time of writing, the Rhythm share price is trading at $1.60, up 6.33%.
Let’s take a closer look at this announcement and what it means for the Rhythm share price.
Why the Rhythm share price opened higher on Tuesday
The Rhythm share price has surged. Climbing from a low of 3.5 cents 12-months ago to a high of $1.675 on 2 March. The company continues to hit significant milestones. In particular, for the commercialisation of its simple, affordable, and effective ColoSTAT blood test….
-
Noosa News20 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News22 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards
-
Noosa News20 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News22 hours agoHelicopter scrambles to site of air crash on K’gari